For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Dr J.C.M. Meijers (1960) has been named Professor of Experimental Vascular Medicine at the Faculty of Medicine of the University of Amsterdam (AMC-UvA).

Dr J.C.M. Meijers (1960) has been named Professor of Experimental Vascular Medicine at the Faculty of Medicine of the University of Amsterdam (AMC-UvA).

Joost Meijers' research focuses on the mechanisms responsible for bleeding, and venous and arterial thrombosis. He studies the process of blood coagulation in order to gain insight into thrombosis risk factors and to identify targets for improved therapies. He is currently investigating the significance of interactions between coagulation and, amongst other conditions, fibrinolysis (the process whereby a blood clot is gradually broken down), cancer and infection. He also develops diagnostic methods for the risk stratification of patients with cardiovascular diseases.

Meijers has served as the head of the Department of Experimental Vascular Medicine at the AMC since 1999, and has been a Senior University Lecturer since 2005. Previously he held successive positions as Royal Netherlands Academy of Arts and Sciences (KNAW) Fellow, University Lecturer and Senior University Lecturer in the Haematology Department of Utrecht University. In the late 1980s, as a NATO Science Fellow of the Netherlands Organisation for Scientific Research (NWO), Meijers worked in the Biochemistry Department of the University of Washington. From 1997 until 2002 he was Established Investigator of the Netherlands Heart Foundation. In 2007, he was awarded an NWO TOP grant for his research into ‘Novel roles of hemostatic proteins in human defence responses towards bacteria'. Meijers is a member of the council of the International Society for Fibrinolysis and Proteolysis.